1983
DOI: 10.1001/archderm.119.11.901
|View full text |Cite
|
Sign up to set email alerts
|

Therapy for basal cell epitheliomas by curettage only. Further study

Abstract: Thorough curettage alone, a simple, effective, inexpensive therapy, has now been used to treat 644 basal cell epitheliomas in 437 patients. Three hundred twenty-eight treatment sites have been evaluated for more than five years. There have been 28 recurrences. Cosmetic results are superior to those obtained with x-ray therapy and electrocoagulation, and appear to be at least equal to those following cryosurgery and excision surgery.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
28
0

Year Published

1988
1988
2020
2020

Publication Types

Select...
3
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 20 publications
(29 citation statements)
references
References 0 publications
1
28
0
Order By: Relevance
“…22 The lack of association with tumor location and size has been observed in analyses of other treatment techniques. 1,2,[11][12][13][14][15][16][17][18][22][23][24][25] However, our recurrence rate of 5.5% (1/18) on the nose is identical to that found by Spiller and Spiller 13 for C&E. In addition, Silverman et al 12 noted a recurrence rate of only 4.5% for BCC of less than 6 mm in high-risk sites after C&E and concluded that it was an effective treatment for small BCC in any anatomical site.…”
Section: Discussionsupporting
confidence: 72%
See 4 more Smart Citations
“…22 The lack of association with tumor location and size has been observed in analyses of other treatment techniques. 1,2,[11][12][13][14][15][16][17][18][22][23][24][25] However, our recurrence rate of 5.5% (1/18) on the nose is identical to that found by Spiller and Spiller 13 for C&E. In addition, Silverman et al 12 noted a recurrence rate of only 4.5% for BCC of less than 6 mm in high-risk sites after C&E and concluded that it was an effective treatment for small BCC in any anatomical site.…”
Section: Discussionsupporting
confidence: 72%
“…The primary risks of C&E are hypertrophic scarring or keloids 15 and hypopigmentation. 1,2,11,15,[33][34][35] Hypertrophic scarring after curettage alone developed in only one of our patients (0.3%), and we noted less significant hypopigmentation compared with that found in sites treated with C&E, evidenced by healing in patients treated with both methods (Fig 1). Other authors have reported similar findings and have recommended avoiding or minimizing electrodesiccation.…”
Section: Discussionmentioning
confidence: 76%
See 3 more Smart Citations